Rilonacept in Diabetes Mellitus Type 1: Safety Study

NCT00962026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: Rilonacept

Sponsor

University of Texas Southwestern Medical Center